Literature DB >> 24391345

Bilateral coronary ostial lesions in cardiovascular syphilis treated by means of percutaneous coronary stenting.

Ravindranath K Shankarappa1, Nagaraja Moorthy1, Arunkumar Panneerselvam1, Satish Karur1, Ramesh Dwarakaprasad1, Manjunath Cholenahalli Nanjappa1.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24391345      PMCID: PMC3853807     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


× No keyword cloud information.
  3 in total

1.  SYPHILITIC AORTITIS. A CLINICOPATHOLOGIC AUTOPSY STUDY OF 100 CASES, 1950 TO 1960.

Authors:  H A HEGGTVEIT
Journal:  Circulation       Date:  1964-03       Impact factor: 29.690

2.  Stents versus coronary-artery bypass grafting for left main coronary artery disease.

Authors:  Ki Bae Seung; Duk-Woo Park; Young-Hak Kim; Seung-Whan Lee; Cheol Whan Lee; Myeong-Ki Hong; Seong-Wook Park; Sung-Cheol Yun; Hyeon-Cheol Gwon; Myung-Ho Jeong; Yangsoo Jang; Hyo-Soo Kim; Pum Joon Kim; In-Whan Seong; Hun Sik Park; Taehoon Ahn; In-Ho Chae; Seung-Jea Tahk; Wook-Sung Chung; Seung-Jung Park
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

Review 3.  Syphilitic coronary artery ostial stenosis resulting in acute myocardial infarction and death.

Authors:  Jamie L W Kennedy; Jeffrey J Barnard; Joseph A Prahlow
Journal:  Cardiology       Date:  2005-09-19       Impact factor: 1.869

  3 in total
  2 in total

1.  Cardiovascular syphilis-associated acute myocardial infarction: A case report.

Authors:  Xiangdong Li; Xue Wang; Zhiyuan Wang; Beibei Du; Cuiying Mao; Heyu Meng; Fanbo Meng; Ping Yang
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

2.  Comparison of coronary artery bypass grafting and percutaneous coronary intervention for syphilitic coronary artery ostial lesions: A 4-year retrospective study.

Authors:  Junyu Han; Wuyang Zheng; Weihua Li; Qiang Xie; Zhengrong Huang; Shuyu Yang
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.